Literature DB >> 19321943

Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004.

Katarzyna Karolewska-Bochenek1, Izabella Lazowska-Przeorek, Piotr Albrecht, Krystyna Grzybowska, Jozef Ryzko, Katarzyna Szamotulska, Andrzej Radzikowski, Piotr Landowski, Elzbieta Krzesiek, Iwona Ignys, Krzysztof Fyderek, Mieczyslawa Czerwionka-Szaflarska, Elzbieta Jarocka-Cyrta.   

Abstract

BACKGROUND/AIMS: The incidence of pediatric inflammatory bowel disease (IBD) in Western countries is on the rise. No prospective studies have been conducted on the epidemiology of pediatric IBD in Poland. The aim of the study was to define the characteristics of new pediatric IBD and assess the incidence of new IBD among children in Poland between 2002 and 2004.
METHODS: Patient records from 24 pediatric gastroenterology centers servicing the whole population of Poland were collected. IBD diagnosis was based on clinical, radiological, endoscopic and histological features.
RESULTS: There were 491 new IBD patients, representing an overall incidence of IBD of 2.7 cases/100,000 children/year. The incidence of Crohn's disease (CD) was 0.6, ulcerative colitis (UC) 1.3, and indeterminate colitis (IC) 0.8. The age-related incidence of IBD was 1.8 in the 0- to 10-year-old age group, rising to 3.7 for the 11- to 18-year age group.
CONCLUSIONS: The overall incidence of IBD (as well as CD, UC and IC) in Poland is lower than that in Western countries. The relative contribution of UC and IC to the overall IBD incidence is higher in Poland than in most Western countries. These findings may suggest a tendency towards under- or misdiagnosis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19321943     DOI: 10.1159/000209382

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children.

Authors:  Jan Józefczuk; Bogdan Marian Woźniewicz
Journal:  ISRN Gastroenterol       Date:  2011-07-06

2.  Clinical value of serum eosinophilic cationic protein assessment in children with inflammatory bowel disease.

Authors:  Andrzej Wędrychowicz; Przemysław Tomasik; Stanisław Pieczarkowski; Kinga Kowalska-Duplaga; Zofia Grzenda-Adamek; Krzysztof Fyderek
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

3.  Incidence Trends and Geographical Variability of Pediatric Inflammatory Bowel Disease in Slovenia: A Nationwide Study.

Authors:  Darja Urlep; Rok Blagus; Rok Orel
Journal:  Biomed Res Int       Date:  2015-11-24       Impact factor: 3.411

4.  Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015.

Authors:  Jan Schwarz; Josef Sýkora; Dominika Cvalínová; Renáta Pomahačová; Jana Klečková; Martin Kryl; Petr Včelák
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

5.  Prevalence of allergic diseases in children with inflammatory bowel disease.

Authors:  Zuzanna Wasielewska; Aleksandra Dolińska; Dominika Wilczyńska; Anna Szaflarska-Popławska; Aneta Krogulska
Journal:  Postepy Dermatol Alergol       Date:  2019-06-18       Impact factor: 1.837

Review 6.  Microbiome, Metabolome and Inflammatory Bowel Disease.

Authors:  Ishfaq Ahmed; Badal C Roy; Salman A Khan; Seth Septer; Shahid Umar
Journal:  Microorganisms       Date:  2016-06-15

Review 7.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

8.  Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017).

Authors:  Petr Jabandziev; Tereza Pinkasova; Lumir Kunovsky; Jan Papez; Martin Jouza; Bara Karlinova; Martina Novackova; Milan Urik; Stefania Aulicka; Ondrej Slaby; Julia Bohosova; Katerina Bajerova; Milan Bajer; Ajay Goel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-05       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.